{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:08:58Z","timestamp":1787497738828,"version":"build-2736575974"},"update-to":[{"DOI":"10.1002\/14651858.cd003914.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,6,3]],"date-time":"2017-06-03T00:00:00Z","timestamp":1496448000000}}],"reference-count":84,"publisher":"Wiley","issue":"6","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003914.pub4","type":"journal-article","created":{"date-parts":[[2017,6,5]],"date-time":"2017-06-05T11:33:11Z","timestamp":1496662391000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Empirical antibiotics targeting gram-positive bacteria for the treatment of febrile neutropenic patients with cancer"],"prefix":"10.1002","volume":"2017","author":[{"given":"Ofrat","family":"Beyar-Katz","sequence":"first","affiliation":[{"name":"Rambam Health Care Campus; Hematology and Bone Marrow Transplantation; Haalyia St. 8 Haifa Israel 3109601"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaakov","family":"Dickstein","sequence":"additional","affiliation":[{"name":"Tel Aviv Sourasky Medical Center; Infectious Diseases Unit; Tel Aviv Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Borok","sequence":"additional","affiliation":[{"name":"Beilinson Hospital, Rabin Medical Center; Department of Medicine E; 39 Jabotinski Street Petah Tikva Israel 49100"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liat","family":"Vidal","sequence":"additional","affiliation":[{"name":"Beilinson Hospital, Rabin Medical Center; Department of Medicine E; 39 Jabotinski Street Petah Tikva Israel 49100"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Leibovici","sequence":"additional","affiliation":[{"name":"Beilinson Hospital, Rabin Medical Center; Department of Medicine E; 39 Jabotinski Street Petah Tikva Israel 49100"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mical","family":"Paul","sequence":"additional","affiliation":[{"name":"Rambam Health Care Campus; Division of Infectious Diseases; Ha-aliya 8 St Haifa Israel 33705"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,6,3]]},"reference":[{"issue":"14","key":"10.1002\/14651858.CD003914.pub4-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1200\/JCO.2013.51.6963","article-title":"Results of a multicenter, controlled, randomized clinical trial evaluating the combination of piperacillin\/tazobactam and tigecycline in high-risk hematologic patients with cancer with febrile neutropenia","volume":"32","author":"Bucaneve","year":"2014","journal-title":"Journal of Clinical Oncology"},{"issue":"3","key":"10.1002\/14651858.CD003914.pub4-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1086\/376637","article-title":"Vancomycin versus placebo for treating persistent fever in patients with neutropenic cancer receiving piperacillin-tazobactam monotherapy","volume":"37","author":"Cometta","year":"2003","journal-title":"Clinical Infectious Diseases"},{"key":"10.1002\/14651858.CD003914.pub4-BIB0003|cit3","unstructured":"Cometta A Kern WV Debock R Paesmans M Vandenbergh M Crokaert F An EORTC-IATG double-blind trial of vancomycin (Van) versus placebo (Pla) for persistent fever in neutropenic cancer patients (NCP) given piperacillin\/tazobactam (PT) monotherapy 41st Interscience Conference on Antimicrobial Agents and Chemotherapy 2001 445"},{"key":"10.1002\/14651858.CD003914.pub4-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1469-0691.2005.01297.x","article-title":"Piperacillin-tazobactam monotherapy in high-risk febrile and neutropenic cancer patients","volume":"12","author":"Viscoli","year":"2006","journal-title":"Clinical Microbiology and Infection"},{"issue":"1","key":"10.1002\/14651858.CD003914.pub4-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ctrv.2003.11.008","article-title":"Vancomycin does not benefit persistently febrile neutropenic people with cancer","volume":"30","author":"Wade","year":"2004","journal-title":"Cancer Treatment Reviews"},{"issue":"7","key":"10.1002\/14651858.CD003914.pub4-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1128\/AAC.31.7.1126","article-title":"Prospective randomized clinical trial of teicoplanin for empiric combined antibiotic therapy in febrile, granulocytopenic acute leukemia patients","volume":"31","author":"Favero","year":"1987","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"6","key":"10.1002\/14651858.CD003914.pub4-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1128\/AAC.28.6.824","article-title":"A randomized prospective study of ceftazidime versus ceftazidime plus flucloxacillin in the empiric treatment of febrile episodes in severely neutropenic patients","volume":"28","author":"Pauw","year":"1985","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"5","key":"10.1002\/14651858.CD003914.pub4-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/infdis\/163.5.951","article-title":"Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients. European Organization for Research and Treatment of Cancer (EORTC) International Antimicrobial Therapy Cooperative Group and the National Cancer Institute of Canada-Clinical Trials Group","volume":"163","author":"EORTC-1991","year":"1991","journal-title":"Journal of Infectious Diseases"},{"issue":"6","key":"10.1002\/14651858.CD003914.pub4-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/jac\/45.6.843","article-title":"A prospective, randomized, double-blinded, placebo-controlled trial of empirical teicoplanin in febrile neutropenia with persistent fever after imipenem monotherapy","volume":"45","author":"Erjavec","year":"2000","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"2","key":"10.1002\/14651858.CD003914.pub4-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0002-9343(86)90257-3","article-title":"Empiric use of vancomycin during prolonged treatment-induced granulocytopenia. Randomized, double-blind, placebo-controlled clinical trial in patients with acute leukemia","volume":"81","author":"Karp","year":"1986","journal-title":"American Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD003914.pub4-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/00000441-198401000-00004","article-title":"A randomized study of tobramycin plus ticarcillin, tobramycin plus cephalothin and ticarcillin, or tobramycin plus mezlocillin in the treatment of infection in neutropenic patients with malignancies","volume":"287","author":"Lawson","year":"1984","journal-title":"American Journal of Medical Sciences"},{"key":"10.1002\/14651858.CD003914.pub4-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0399-077X(05)80140-4","article-title":"Empirical treatment of febrile episodes in cancer patients with prolonged neutropenia: comparative study of ceftazidime alone, ceftazidime+amikacin, and ceftazidime+vancomycin","volume":"21","author":"Marie","year":"1991","journal-title":"Medicine et Maladies Infectieuses (Medicine and Infectious Diseases)"},{"issue":"37","key":"10.1002\/14651858.CD003914.pub4-BIB0013|cit13","first-page":"1968","article-title":"Antibiotic therapy protocol using ceftazidime 3g\/day alone or in combination with vancomycin or amikacin. In febrile episodes in neutropenic patients","volume":"17","author":"Marie","year":"1988","journal-title":"Presse Medicale (Medical Press)"},{"key":"10.1002\/14651858.CD003914.pub4-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/jac\/41.suppl_4.57","article-title":"Neutropenic infections: a review of the French Febrile Aplasia Study Group trials in 608 febrile neutropenic patients","volume":"41 Suppl D","author":"Marie","year":"1998","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"5","key":"10.1002\/14651858.CD003914.pub4-BIB0015|cit15","first-page":"275","article-title":"Should vancomycin be used empirically in febrile patients with prolonged and profound neutropenia? Results of a randomized trial","volume":"2","author":"Pico","year":"1993","journal-title":"European Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD003914.pub4-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/BF01643959","article-title":"Empiric antimicrobial therapy in febrile granulocytopenic patients. Randomized prospective comparison of amikacin plus piperacillin with or without parenteral trimethoprim\/sulphamethoxazole","volume":"14","author":"Menichetti","year":"1986","journal-title":"Infection"},{"key":"10.1002\/14651858.CD003914.pub4-BIB0017|cit17","unstructured":"Molina F Pedro L Rosell R Barnadas A Font A Maurel J Randomized open and prospective study of two antibiotic schedules (with and without teicoplanin) for post-chemotherapy episodes of neutropenic fever Oncologia: IV Congresso Nacional de la SEOM 1993 247"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD003914.pub4-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2141.1990.tb07926.x","article-title":"Options and limitations of teicoplanin in febrile granulocytopenic patients","volume":"76","author":"Pauw","year":"1990","journal-title":"British Journal of Haematology"},{"issue":"4","key":"10.1002\/14651858.CD003914.pub4-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1128\/AAC.35.4.672","article-title":"Ceftazidime as monotherapy or combined with teicoplanin for initial empiric treatment of presumed bacteremia in febrile granulocytopenic patients","volume":"35","author":"Novakova","year":"1991","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1002\/14651858.CD003914.pub4-BIB0020|cit20","unstructured":"Novakova I Donnelly JP Muytjens HL De Pauw B Ceftazidime as monotherapy or combined with teicoplanin for initial empiric treatment of presumed bacteremia in febrile granulocytopenic patients 28th Interscience Conference Antimicrobials Agents and Chemotherapy American Society of Microbiology 1988 16"},{"issue":"5","key":"10.1002\/14651858.CD003914.pub4-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1128\/AAC.36.5.1062","article-title":"Vancomycin is not an essential component of the initial empiric treatment regimen for febrile neutropenic patients receiving ceftazidime: a randomized prospective study","volume":"36","author":"Ramphal","year":"1992","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"2","key":"10.1002\/14651858.CD003914.pub4-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1128\/AAC.31.2.191","article-title":"Randomized prospective study of ceftazidime versus ceftazidime plus cephalothin in empiric treatment of febrile episodes in severely neutropenic patients","volume":"31","author":"Verhagen","year":"1987","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1002\/14651858.CD003914.pub4-BIB0023|cit23","unstructured":"Berger C Kindli K Niggli D Nadal D Meropenem therapy in febrile neutropenic children with cancer seldom affords addition of a glycopeptide 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy American Society for Microbiology 2002 251"},{"issue":"740","key":"10.1002\/14651858.CD003914.pub4-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/joim.1997.242.s740.69","article-title":"Empirical and subsequent use of antibacterial agents in the febrile neutropenic patient","volume":"242","author":"Pauw","year":"1997","journal-title":"Journal of Internal Medicine. Supplement"},{"issue":"8","key":"10.1002\/14651858.CD003914.pub4-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/0959-8049(96)00050-0","article-title":"Early identification of neutropenic patients at risk of grampositive bacteraemia and the impact of empirical administration of vancomycin","volume":"32A","author":"Dompeling","year":"1996","journal-title":"European Journal of Cancer"},{"key":"10.1002\/14651858.CD003914.pub4-BIB0026|cit26","unstructured":"Elting LS Rubenstein EB Rolston KV Manzullo E Bodey GP Impact of vancomycin (vanc) use on duration of fever and mortality in neutropenic patients with gram positive bacteremia (GPB) Proceedings of the Annual Meeting of the American Society of Clinial Oncology 1996"},{"key":"10.1002\/14651858.CD003914.pub4-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1086\/514550","article-title":"Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials","volume":"25","author":"Elting","year":"1997","journal-title":"Clinical Infectious Diseases"},{"issue":"10","key":"10.1002\/14651858.CD003914.pub4-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1200\/JCO.1983.1.10.597","article-title":"Combination of amikacin and carbenicillin with or without cefazolin as empirical treatment of febrile neutropenic patients. The International Antimicrobial Therapy Project Group of the European Organization for Research and Treatment of Cancer","volume":"1","author":"EORTC-1983","year":"1983","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD003914.pub4-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/BF01643253","article-title":"Treatment of severe sepsis in bone marrow transplant recipients with teicoplanin in combination with beta-lactams and aminoglycosides","volume":"19","author":"Fauser","year":"1991","journal-title":"Infection"},{"key":"10.1002\/14651858.CD003914.pub4-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00006454-198803000-00006","article-title":"Ceftazidime with or without vancomycin vs. cephalothin, carbenicillin and gentamicin as the initial therapy of the febrile neutropenic pediatric cancer patient","volume":"7","author":"Granowetter","year":"1988","journal-title":"Pediatric Infectious Diseases Journal"},{"key":"10.1002\/14651858.CD003914.pub4-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0002-9343(86)90258-5","article-title":"Aztreonam therapy in neutropenic patients with cancer","volume":"81","author":"Jones","year":"1986","journal-title":"American Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD003914.pub4-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1128\/AAC.30.1.64","article-title":"Randomized comparison between two ceftazidime-containing regimens and cephalothin-gentamicin-carbenicillin in febrile granulocytopenic cancer patients","volume":"30","author":"Kramer","year":"1986","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1002\/14651858.CD003914.pub4-BIB0033|cit33","first-page":"167","article-title":"Teicoplanin in the therapy of Gram-positive infections in immunocomprised patients","volume":"38","author":"Libanore","year":"1991","journal-title":"Giornale Italiano di Chemioterapia (Italian Journal of Chemotherapy)"},{"key":"10.1002\/14651858.CD003914.pub4-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2141.1990.tb07935.x","article-title":"A randomized prospective study of ceftazidime and ciprofloxacin with or without teicoplanin as an empiric antibiotic regimen for febrile neutropenic patients","volume":"76 Suppl 2","author":"Lim","year":"1990","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD003914.pub4-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF01700277","article-title":"Interventional antimicrobial therapy in febrile neutropenic patients","volume":"69","author":"Link","year":"1994","journal-title":"Annals of Hematology"},{"key":"10.1002\/14651858.CD003914.pub4-BIB0036|cit36","first-page":"38","article-title":"Interventional antimicrobial strategy in febrile neutropenic patients. Results of a multicenter study in 1260 patients with hematological malignancies. The Interventional Antimicrobial Strategy Study Group, Paul Erlich Society for Chemotherapy","volume":"13","author":"Maschmeyer","year":"1990","journal-title":"Onkologie (Oncology)"},{"issue":"5","key":"10.1002\/14651858.CD003914.pub4-BIB0037|cit37","first-page":"63","article-title":"Analyze the curative effect of norvancomycin using at 44 patients with agranulocyte after chemotherapy","volume":"6","author":"Liu","year":"2000","journal-title":"Contemporary Medicine"},{"issue":"2","key":"10.1002\/14651858.CD003914.pub4-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/clinids\/15.2.290","article-title":"Piperacillin plus amikacin vs. piperacillin plus amikacin plus teicoplanin for empirical treatment of febrile episodes in neutropenic patients receiving quinolone prophylaxis","volume":"15","author":"Martino","year":"1992","journal-title":"Clinical Infectious Diseases"},{"key":"10.1002\/14651858.CD003914.pub4-BIB0039|cit39","first-page":"19","article-title":"Teicoplanin in the treatment of gram-positive bacteraemia in neutropenic patients","volume":"76 Suppl 2","author":"Micozzi","year":"1990","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD003914.pub4-BIB0040|cit40","first-page":"1194","article-title":"A randomized study of the empirical antibiotic therapy of the infections in neutropenic patients, affected by neoplastic diseases in paediatric age and under a fever attack","volume":"39","author":"Moroni","year":"1987","journal-title":"Giornale di Malattie Infettive e Parassitarie (Journal of Infectious and Parasitic Dieases)"},{"issue":"6","key":"10.1002\/14651858.CD003914.pub4-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/jac\/25.6.985","article-title":"Teicoplanin as modification of initial empirical therapy in febrile granulocytopenic patients","volume":"25","author":"Novakova","year":"1990","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1002\/14651858.CD003914.pub4-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0002-9343(82)90594-0","article-title":"Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia","volume":"72","author":"Pizzo","year":"1982","journal-title":"American Journal of Medicine"},{"key":"10.1002\/14651858.CD003914.pub4-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1056\/NEJM198608283150905","article-title":"A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia","volume":"315","author":"Pizzo","year":"1986","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD003914.pub4-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"30","DOI":"10.7326\/0003-4819-108-1-30","article-title":"Gram-positive infections and the use of vancomycin in 550 episodes of fever and neutropenia","volume":"108","author":"Rubin","year":"1988","journal-title":"Annals of Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD003914.pub4-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1080\/21505594.2016.1159366","article-title":"Epidemiology of antimicrobial resistance in bloodstream infections","volume":"7","author":"Akova","year":"2016","journal-title":"Virulence"},{"issue":"12","key":"10.1002\/14651858.CD003914.pub4-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.3324\/haematol.2013.091025","article-title":"European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia","volume":"98","author":"Averbuch","year":"2013","journal-title":"Haematologica"},{"key":"10.1002\/14651858.CD003914.pub4-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJMoa044097","article-title":"Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia","volume":"353","author":"Bucaneve","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003914.pub4-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejcsup.2007.06.004","article-title":"Empirical use of anti-Gram-positive antibiotics in febrile neutropaenic cancer patients with acute leukaemia","volume":"5 Suppl","author":"Cometta","year":"2007","journal-title":"European Journal of Cancer"},{"issue":"3","key":"10.1002\/14651858.CD003914.pub4-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/infdis\/161.3.397","article-title":"The design, analysis, and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient. Report of a consensus panel","volume":"161","author":"From the Immunocompromised Host Society","year":"1990","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD003914.pub4-BIB0050|cit50","unstructured":"Consort statement http:\/\/www.consort-statement.org\/"},{"issue":"8","key":"10.1002\/14651858.CD003914.pub4-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1086\/322646","article-title":"A multicenter, double-blind, placebo-controlled trial comparing piperacillin-tazobactam with and without amikacin as empiric therapy for febrile neutropenia","volume":"33","author":"Favero","year":"2001","journal-title":"Clinical Infectious Diseases"},{"key":"10.1002\/14651858.CD003914.pub4-BIB0052|cit52","unstructured":"Antibiotic resistance and antibiotic consumption http:\/\/ecdc.europa.eu\/EN\/HEALTHTOPICS\/ANTIMICROBIAL-RESISTANCE-AND-CONSUMPTION\/Pages\/antimicrobial-resistance-and-anitmicrobial-consumption.aspx"},{"issue":"7109","key":"10.1002\/14651858.CD003914.pub4-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD003914.pub4-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/infdis\/137.1.14","article-title":"Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. The EORTC international antimicrobial therapy project group","volume":"137","author":"Schimpff","year":"1978","journal-title":"Journal of Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD003914.pub4-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1128\/AAC.29.2.263","article-title":"Prospective randomized comparison of three antibiotic regimens for empirical therapy of suspected bacteremic infection in febrile granulocytopenic patients","volume":"29","author":"Klastersky","year":"1986","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"27","key":"10.1002\/14651858.CD003914.pub4-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1056\/NEJM198712313172703","article-title":"Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia","volume":"317","author":"The EORTC International Antimicrobial Therapy Cooperative Group","year":"1987","journal-title":"New England Journal of Medicine"},{"issue":"7 Pt 1","key":"10.1002\/14651858.CD003914.pub4-BIB0057|cit57","first-page":"584","article-title":"Efficacy and toxicity of single daily doses of amikacin and ceftriaxone versus multiple daily doses of amikacin and ceftazidime for infection in patients with cancer and granulocytopenia","volume":"119","author":"The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer","year":"1993","journal-title":"Annals of Internal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD003914.pub4-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1128\/AAC.39.2.445","article-title":"Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer","volume":"39","author":"Cometta","year":"1995","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"5","key":"10.1002\/14651858.CD003914.pub4-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1128\/AAC.40.5.1108","article-title":"Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto Infection Program","volume":"40","author":"Cometta","year":"1996","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1002\/14651858.CD003914.pub4-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/jac\/dki004","article-title":"Safety and efficacy of glycopeptide antibiotics","volume":"55","author":"Finch","year":"2005","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"5","key":"10.1002\/14651858.CD003914.pub4-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clinical Infectious Diseases"},{"key":"10.1002\/14651858.CD003914.pub4-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"979","DOI":"10.7326\/0003-4819-142-12_Part_1-200506210-00008","article-title":"Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients","volume":"142","author":"Gafter-Gvili","year":"2005","journal-title":"Annals of Internal Medicine"},{"issue":"7","key":"10.1002\/14651858.CD003914.pub4-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"2836\u201340","DOI":"10.1172\/JCI68834","article-title":"Mechanisms of vancomycin resistance in Staphylococcus aureus","volume":"124","author":"Gardete","year":"2014","journal-title":"Journal of Clinical Investigation"},{"issue":"1","key":"10.1002\/14651858.CD003914.pub4-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0002-9343(78)90188-2","article-title":"Granulocytopenia in hospitalized patients. II. A prospective comparison of two antibiotic regimens in the empiric therapy of febrile patients","volume":"64","author":"Gurwith","year":"1978","journal-title":"American Journal of Medicine"},{"key":"10.1002\/14651858.CD003914.pub4-BIB0065|cit65","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011] The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD003914.pub4-BIB0066|cit66","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011) The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org"},{"issue":"3","key":"10.1002\/14651858.CD003914.pub4-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/infdis\/161.3.381","article-title":"From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever","volume":"161","author":"Hughes","year":"1990","journal-title":"Journal of Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD003914.pub4-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1128\/AAC.01908-13","article-title":"Trends in antibiotic resistance in coagulase-negative staphylococci in the United States, 1999 to 2012","volume":"58","author":"May","year":"2014","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"7","key":"10.1002\/14651858.CD003914.pub4-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s10096-013-1819-7","article-title":"Recent changes in bacteremia in patients with cancer: a systematic review of epidemiology and antibiotic resistance","volume":"32","author":"Montassier","year":"2013","journal-title":"European Journal of Clinical Microbiology and Infectious Diseases"},{"issue":"6","key":"10.1002\/14651858.CD003914.pub4-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1128\/AAC.38.6.1363","article-title":"Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit","volume":"38","author":"Montecalvo","year":"1994","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"1","key":"10.1002\/14651858.CD003914.pub4-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s15010-013-0525-9","article-title":"The current spectrum of infection in cancer patients with chemotherapy related neutropenia","volume":"42","author":"Nesher","year":"2014","journal-title":"Infection"},{"issue":"24","key":"10.1002\/14651858.CD003914.pub4-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Statistics in Medicine"},{"issue":"5","key":"10.1002\/14651858.CD003914.pub4-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/annonc\/mdq442","article-title":"Management of sepsis in neutropenic patients: guidelines from the infectious diseases working party of the German Society of Hematology and Oncology","volume":"22","author":"Penack","year":"2011","journal-title":"Annals of Oncology"},{"issue":"4","key":"10.1002\/14651858.CD003914.pub4-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/00005792-198407000-00001","article-title":"Hickman catheter infections in patients with malignancies","volume":"63","author":"Press","year":"1984","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1002\/14651858.CD003914.pub4-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1155\/2014\/702621","article-title":"Mortality related to coagulase-negative staphylococcal bacteremia in febrile neutropenia: A cohort study","volume":"25","author":"Rosa","year":"2014","journal-title":"Canadian Journl of Infectious Diseases and Medical Microbiology"},{"issue":"5","key":"10.1002\/14651858.CD003914.pub4-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"issue":"26","key":"10.1002\/14651858.CD003914.pub4-BIB0077|cit77","first-page":"565","article-title":"Staphylococcus aureus resistant to vancomycin - United States, 2002","volume":"51","author":"Sievert","year":"2002","journal-title":"Morbidity and Mortality Weekly Report"},{"issue":"2","key":"10.1002\/14651858.CD003914.pub4-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3201\/eid0702.010237","article-title":"Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus","volume":"7","author":"Tenover","year":"2001","journal-title":"Emerging Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD003914.pub4-BIB0079|cit79","first-page":"177","article-title":"Epidemiology of febrile neutropenia in patients with hematological disease-a prospective multicentre survey in China","volume":"37","author":"Yan","year":"2016","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"issue":"3","key":"10.1002\/14651858.CD003914.pub4-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3892\/mco.2015.722","article-title":"Evaluation of febrile neutropenic episodes in adult patients with solid tumors","volume":"4","author":"Yapici","year":"2016","journal-title":"Molecular and Clinical Oncology"},{"issue":"4","key":"10.1002\/14651858.CD003914.pub4-BIB0081|cit81","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003914","article-title":"Additional anti-Gram-positive antibiotic treatment for febrile neutropaenic cancer patients","author":"Paul","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD003914.pub4-BIB0082|cit82","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003914.pub2","article-title":"Additional anti-Gram-positive antibiotic treatment for febrile neutropenic cancer patients","author":"Paul","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD003914.pub4-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/jac\/dki028","article-title":"Empirical antibiotics against Gram-positive infections for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials","volume":"55","author":"Paul","year":"2005","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"1","key":"10.1002\/14651858.CD003914.pub4-BIB0084|cit84","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003914.pub3","article-title":"Empirical antibiotics targeting Gram-positive bacteria for the treatment of febrile neutropenic patients with cancer","author":"Paul","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD003914.pub4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,17]],"date-time":"2024-03-17T23:17:31Z","timestamp":1710717451000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD003914.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,6,3]]},"references-count":84,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,6]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003914.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,3]]}}}